CAS: 251945-92-3 - Derenofylline
Formula:C18H20N4O
InChI:InChI=1/C18H20N4O/c23-14-8-6-13(7-9-14)20-18-15-10-11-19-17(15)21-16(22-18)12-4-2-1-3-5-12/h1-5,10-11,13-14,23H,6-9H2,(H2,19,20,21,22)/t13-,14-
InChI key:InChIKey=RBZNJGHIKXAKQE-HDJSIYSDNA-N
SMILES:OC1CCC(NC=2N=C(N=C3NC=CC32)C=4C=CC=CC4)CC1
- Synonyms:
- Cyclohexanol, 4-[(2-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-, trans-
- SLV 320
- trans-4-[(2-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexanol
- Cyclohexanol, 4-[(2-phenyl-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-, trans-
- 4-[(4-trans-Hydroxycyclohexyl)amino]-2-phenyl-7H-pyrrolo[2,3-d]pyrimidine
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Cyclohexanol, 4-[(2-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-, trans- REF: IN-DA002QU9CAS: 251945-92-3 | 98% | 46.00 €~223.00 € | Thu 02 Jan 25 | |
Derenofylline REF: TM-T8312CAS: 251945-92-3 | 98.09% | 35.00 €~491.00 € | Tue 07 Jan 25 | |
Derenofylline REF: 3D-BKA94592CAS: 251945-92-3 | Min. 95% | To inquire | Tue 11 Feb 25 |
Cyclohexanol, 4-[(2-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-, trans-
CAS:251945-92-3
Formula:
C18H20N4O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
308.3776
Ref: IN-DA002QU9
10mg | 46.00 € | ||
100mg | 157.00 € | ||
250mg | 223.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
Derenofylline
CAS:251945-92-3
Derenofylline is a selective and potent adenosine A(1) antagonist in vitro (Ki=1 nM)
Formula:
C18H20N4O
Purity:
98.09%
Color and Shape:
Solid
Molecular weight:
308.38
Ref: TM-T8312
5mg | 49.00 € | ||
10mg | 74.00 € | ||
25mg | 144.00 € | ||
50mg | 250.00 € | ||
100mg | 360.00 € | ||
200mg | 491.00 € | ||
1mL*10mM (DMSO) | 50.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Derenofylline
CAS:251945-92-3
Derenofylline is a drug that belongs to a class of adenosine receptor antagonists and is …
Formula:
C18H20N4O
Purity:
Min. 95%
Molecular weight:
308.38 g/mol
Ref: 3D-BKA94592
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 11 Feb 2025